Login to Your Account

Financings Roundup

Symphogen Financing Largest for Private European Biotech

By Tom Wall

Friday, January 7, 2011
Symphogen A/S, of Copenhagen, Denmark, has raised what it said is the largest financing ever for a private European biotech company with a $131 million preferred stock placement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription